|
End-of-day quote
Mexican S.E.
2026-09-24
|
5-day change | 1st Jan Change | ||
| 19.47 MXN | +5.59% |
|
+14.06% | -22.43% |
| 09-14 | Ocugen Insider Sold Shares Worth $589,110, According to a Recent SEC Filing | MT |
| 09-01 | Ocugen Doses First Patient in Trial of Potential Eye Disease Drug | MT |
| Market Cap | 339M 5.99B 298M 281M 257M 480M 32.55B 484M 3.37B 1.31B 16.57B 1.27B 1.25B 53.91B | P/E 2026 * |
-3.85x | P/E 2027 * | -3.57x |
|---|---|---|---|---|---|
| Enterprise Value | 339M 5.99B 298M 281M 257M 480M 32.55B 484M 3.37B 1.31B 16.57B 1.27B 1.25B 53.91B | EV / Sales 2026 * |
71.3x | EV / Sales 2027 * | 136x |
| Free-Float |
98.42% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OCGN | Delayed | |
Tradegate
| 2H51 | Real-time | |
|
CBOE
| OCGN | Real-time | |
|
Boerse Muenchen
| 2H51 | Real-time | |
|
Börse Stuttgart
| 2H51 | Delayed | |
|
Deutsche Boerse AG
| 2H51 | Delayed | |
|
Mexican S.E.
| OCGN * | End-of-day quote |
Last Transcript: Ocugen, Inc.
| 1 day | +5.59% | ||
| 1 week | +14.06% | ||
| Current month | -22.12% | ||
| 1 month | -22.12% | ||
| 3 months | -17.67% | ||
| 6 months | -41.00% | ||
| Current year | -22.43% |
| 1 week | 18 |  | 19.5 |
| 1 month | 17.07 | | 24 |
| Current year | 17.07 | | 45.5 |
| 1 year | 17.07 | | 45.5 |
| 3 years | 6.05 | | 45.5 |
| 5 years | 6.05 | | 335 |
| 10 years | 6.05 | | 335 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 62 | 2019-09-26 |
| Director of Finance/CFO | - | 2026-02-08 | |
Paul Staid
COO | Chief Operating Officer | - | 2026-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Shankar Musunuri
CHM | Chairman | 62 | 2019-09-26 |
Uday Kompella
BRD | Director/Board Member | 59 | 2013-08-31 |
Junge Zhang
BRD | Director/Board Member | 59 | 2019-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.59% | +14.06% | - | - | 339M | |
| +1.46% | +4.59% | +8.65% | +33.71% | 47.56B | |
| +2.67% | +2.07% | +51.74% | +38.37% | 44.09B | |
| -1.38% | +1.84% | +9.13% | +88.88% | 41.5B | |
| +4.78% | +1.48% | +359.03% | +566.20% | 40.88B | |
| -0.62% | -1.61% | +5.30% | +46.02% | 29.67B | |
| +0.56% | +0.88% | +24.79% | +155.71% | 17.23B | |
| +2.05% | +1.09% | +25.56% | +41.67% | 15.06B | |
| +3.39% | -3.49% | - | - | 14.65B | |
| +7.38% | +2.34% | +3.80% | - | 13.82B | |
| Average | +2.59% | +0.07% | +61.00% | +138.65% | 29.39B | |
| Weighted average by Cap. | +1.89% | +0.94% | +75.14% | +147.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.76M 84.03M 4.18M 3.94M 3.6M 6.73M 457M 6.78M 47.34M 18.34M 232M 17.86M 17.47M 756M | 2.5M 44.16M 2.2M 2.07M 1.89M 3.54M 240M 3.56M 24.88M 9.64M 122M 9.39M 9.18M 397M |
| Net income | -87.21M -1.54B -76.71M -72.31M -65.97M -123M -8.37B -124M -868M -336M -4.26B -327M -320M -13.86B | -97.94M -1.73B -86.14M -81.21M -74.09M -139M -9.4B -140M -975M -378M -4.78B -368M -360M -15.57B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | MX$19.47 | +5.59% | 92 |
| 26-09-23 | MX$18.44 | +8.03% | 2,154 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCGN Stock
- OCGN * Stock
Select your edition
All financial news and data tailored to specific country editions
